VERDE BIO HOLDINGS, INC. (APHD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue Quarterly

-8K 0 8K 16K 24K Q3 '14: 122 Q4 '14: -6 Q1 '15: 228 Q2 '15: 30 Q3 '15: 0 Q4 '15: 0 Q1 '17: 11.6K Q2 '17: 19.4K Q2 '17: 19.4K Q3 '17: 22.5K Q1 '18: 11.1K Q2 '18: 16.8K Q3 '18: 13.9K Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q3 '20: 0 Q3 '21: 2.3K Q4 '14 Q3 '15 Q2 '17 Q1 '18 Q4 '18 Q3 '19 Q3 '21

Gross Profit Quarterly

0 7K 14K 21K Q1 '17: 5.9K Q2 '17: 8.2K Q2 '17: 8.2K Q3 '17: 18.6K Q1 '18: 6.1K Q2 '18: 7.1K Q3 '18: 5.3K Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q2 '17 Q3 '17 Q2 '18 Q4 '18 Q2 '19 Q4 '19

Operating Income Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q4 '19: -11.7K Q1 '20: -43.8K Q2 '20: -35.3K Q3 '20: -52.8K Q4 '20: -127.4K Q1 '21: -341.6K Q2 '21: -97.7K Q3 '21: -100.9K Q4 '21: -2.4M Q1 '22: -677.4K Q2 '22: -1.6M Q3 '22: -445.6K Q4 '22: -420.5K Q1 '23: -698.5K Q2 '23: -125.3K Q3 '23: -414.2K Q4 '23: -402K Q1 '24: -327K Q2 '24: -303.3K Q3 '24: -410.5K Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24

Net Income Quarterly

-3M -2M -1M 0 1M 2M 3M Q4 '19: -659.6K Q1 '20: -386.4K Q2 '20: -260.7K Q3 '20: -376.7K Q4 '20: -551.5K Q1 '21: -910.5K Q2 '21: 300.9K Q3 '21: -4.3K Q4 '21: -2.7M Q1 '22: 0 Q2 '22: -1.6M Q3 '22: -725.9K Q4 '22: -436.9K Q1 '23: -786.6K Q2 '23: -154.3K Q3 '23: -439.8K Q4 '23: -529.4K Q1 '24: -336.6K Q2 '24: -350.8K Q3 '24: -1.5M Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24

Cost of Revenue Quarterly

0 4K 8K 12K Q1 '17: 5.7K Q2 '17: 11.2K Q2 '17: 11.2K Q3 '17: 3.9K Q4 '17: 1.3K Q1 '18: 5K Q2 '18: 9.7K Q3 '18: 8.6K Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '17 Q2 '17 Q4 '17 Q2 '18 Q4 '18 Q2 '19 Q4 '19

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q4 '19: -9.4K Q1 '20: -9.3K Q2 '20: -31.2K Q3 '20: -42.6K Q4 '20: -94.7K Q1 '21: -61.8K Q2 '21: -80.1K Q3 '21: -72.8K Q4 '21: -470.5K Q1 '22: -612.9K Q2 '22: -229.6K Q3 '22: -298.6K Q4 '22: -8.8K Q1 '23: -427.1K Q2 '23: 16.6K Q3 '23: -306.5K Q4 '23: -155.2K Q1 '24: -388.6K Q2 '24: -240.3K Q3 '24: -314.3K Q1 '20 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24

Free Cash Flow Quarterly

-3M -2M -1M 0 1M 2M 3M Q4 '11: -16.5K Q1 '12: -19.1K Q2 '12: -11.2K Q3 '12: -5K Q4 '12: 2.1K Q1 '13: -417 Q3 '13: -103 Q1 '14: -30.8K Q2 '14: -1.5K Q3 '14: -21.8K Q1 '22: -738.5K Q2 '22: -2.7M Q3 '22: -328.6K Q4 '22: -271.8K Q1 '23: -434.1K Q2 '23: 16.6K Q3 '23: -306.5K Q4 '23: -155.2K Q1 '24: -388.6K Q2 '24: -240.3K Q1 '12 Q4 '12 Q1 '14 Q1 '22 Q4 '22 Q3 '23 Q2 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 700M 1.4B 2.1B Q1 '11: 5.9M Q1 '12: 6.3M Q1 '15: 139.5K Q1 '16: 46.3M Q1 '17: 35.9M Q1 '18: 3.3M Q2 '18: 7.7M Q3 '18: 14.7M Q1 '19: 896.6M Q2 '19: 1.3M Q3 '19: 1.1M Q1 '20: 1.1M Q2 '20: 1.5M Q3 '20: 1.7M Q2 '21: 43M Q3 '21: 51M Q2 '22: 1.2B Q3 '23: 1.4B Q3 '24: 1.9B Q1 '11 Q1 '16 Q2 '18 Q2 '19 Q2 '20 Q3 '21 Q3 '24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q4 '15: -1.00 Q1 '16: -0.33 Q2 '16: 0.38 Q3 '16: 0.61 Q1 '18: -1.49 Q2 '18: -1.53 Q3 '18: -1.51 Q4 '18: -0.12 Q1 '20: -1.07 Q2 '20: -1.14 Q3 '20: -1.28 Q4 '20: -1.06 Q1 '21: -0.74 Q2 '21: -0.56 Q3 '21: -0.34 Q4 '21: -0.03 Q1 '22: 0.01 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '16 Q1 '18 Q4 '18 Q3 '20 Q2 '21 Q1 '22 Q4 '22

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.